Evaluation of a novel quantitative canine species-specific point-of-care assay for C-reactive protein

dc.contributor.authorHindenberg, Sarah
dc.contributor.authorKeßler, Melanie
dc.contributor.authorZielinsky, Sabine
dc.contributor.authorLangenstein, Judith
dc.contributor.authorMoritz, Andreas
dc.contributor.authorBauer, Natali
dc.date.accessioned2022-11-18T09:53:27Z
dc.date.available2019-05-20T09:54:10Z
dc.date.available2022-11-18T09:53:27Z
dc.date.issued2018
dc.description.abstractBackground: Species-specific point-of-care tests (POCT) permit a rapid analysis of canine C-reactive protein (CRP), enabling veterinarians to include CRP in clinical decisions. Aim of the study was to evaluate a novel POCT for canine CRP (Point Stripâ TM Canine CRP Assay) run on a small in-house-analyzer (Point Reader TM V) using lithium heparin plasma and to compare assay performance to an already established canine CRP assay (Gentian Canine CRP Immunoassay) run on two different bench top analyzers serving as reference methods (ABX Pentra 400, AU 5800). Linearity was assessed by stepwise dilution of plasma samples with high CRP concentrations. Limit of quantification (LoQ) was determined by repeated measurements of samples with low CRP concentrations. Coefficient of variation (CV) at low (10-50 mg/l), moderate (50-100 mg/l), and high (100-200 mg/l) CRP concentrations was investigated as well as possible interferences. Method comparison study was performed using 45 samples of healthy and diseased dogs. Quality criteria were fulfilled if the total observed error (TEobs=2CV%+bias%) was below the minimal total allowable error of 44.4% (TE min). Additionally, a reference range (n =60 healthy dogs) was established.Results: Linearity was present at CRP concentrations of 10-132 mg/l (≙ 361 mg/l CRP with reference method) with a LoQ set at 10 mg/l. At moderate to high CRP concentrations, intra- and inter-assay CVs were< =8% and <=11% respectively, while CVs<=22% and <=28% were present at low concentrations. No interferences were observed at concentrations of 4 g/l hemoglobin, 800 mg/l bilirubin and 8 g/l triglycerides. Method comparison study demonstrated an excellent correlation with both reference methods (r =0.98 for ABX Pentra 400; 0.99 for AU 5800), though revealing a proportional bias of 19.7% (ABX Pentra 400) and 10.7% (AU 5800) respectively. TEobs was 26.7-31.9% and 16.7-21.9% and thus < TEmin. Healthy dogs presented with CRP values <=11.9 mg/l. Conclusions The POCT precisely detects canine CRP at clinically relevant moderate and high CRP concentrations. The assay correlates well with both reference methods. Due to the bias, however, follow-up examinations should be performed with the same assay and analyzer.en
dc.identifier.urihttp://nbn-resolving.de/urn:nbn:de:hebis:26-opus-146011
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/9436
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-8824
dc.language.isoende_DE
dc.rightsNamensnennung 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectacute phase proteinen
dc.subjectC-reactive proteinen
dc.subjectcanineen
dc.subjectmethod validationen
dc.subjectpoint-of-care assayen
dc.subjectpoint-of-care analyzeren
dc.subject.ddcddc:630de_DE
dc.titleEvaluation of a novel quantitative canine species-specific point-of-care assay for C-reactive proteinen
dc.typearticlede_DE
local.affiliationFB 10 - Veterinärmedizinde_DE
local.opus.fachgebietVeterinärmedizinde_DE
local.opus.id14601
local.opus.instituteDepartment of Veterinary Clinical Sciences, Clinical Pathology and Clinical Pathophysiologyde_DE
local.source.freetextBMC Veterinary Research 14:99de_DE
local.source.urihttps://doi.org/10.1186/s12917-018-1415-2

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
10.1186_s12917_018_1415_2.pdf
Größe:
958.65 KB
Format:
Adobe Portable Document Format